These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23383328)

  • 1. Expression microarray meta-analysis identifies genes associated with Ras/MAPK and related pathways in progression of muscle-invasive bladder transition cell carcinoma.
    Ewald JA; Downs TM; Cetnar JP; Ricke WA
    PLoS One; 2013; 8(2):e55414. PubMed ID: 23383328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of progression-related genes in the evolution of superficial to invasive transitional cell carcinoma of the bladder.
    Izawa JI; Slaton JW; Kedar D; Karashima T; Perrotte P; Czerniak B; Grossman HB; Dinney CP
    Oncol Rep; 2001; 8(1):9-15. PubMed ID: 11115562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in gene expression between noninvasive and invasive transitional cell carcinoma of the human bladder using complementary deoxyribonucleic acid microarray: preliminary results.
    Elsamman E; Fukumori T; Ewis AA; Ali N; Kajimoto K; Shinohara Y; Ishikawa M; Takahashi M; Nishitani MA; Baba Y; Kanayama HO
    Urol Oncol; 2006; 24(2):109-15. PubMed ID: 16520272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implication of RAF and RKIP genes in urinary bladder cancer.
    Zaravinos A; Chatziioannou M; Lambrou GI; Boulalas I; Delakas D; Spandidos DA
    Pathol Oncol Res; 2011 Jun; 17(2):181-90. PubMed ID: 20853079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential PTEN protein expression profiles in superficial versus invasive bladder cancers.
    Koksal IT; Yasar D; Dirice E; Usta MF; Karauzum S; Luleci G; Baykara M; Sanlioglu S
    Urol Int; 2005; 75(2):102-6. PubMed ID: 16123561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bladder Tumor Subtype Commitment Occurs in Carcinoma
    Wullweber A; Strick R; Lange F; Sikic D; Taubert H; Wach S; Wullich B; Bertz S; Weyerer V; Stoehr R; Breyer J; Burger M; Hartmann A; Strissel PL; Eckstein M
    Cancer Res; 2021 Mar; 81(6):1552-1566. PubMed ID: 33472889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: use of cDNA array analysis of gene expression profiles.
    Modlich O; Prisack HB; Pitschke G; Ramp U; Ackermann R; Bojar H; Vögeli TA; Grimm MO
    Clin Cancer Res; 2004 May; 10(10):3410-21. PubMed ID: 15161696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.
    Shen SS; Smith CL; Hsieh JT; Yu J; Kim IY; Jian W; Sonpavde G; Ayala GE; Younes M; Lerner SP
    Cancer; 2006 Jun; 106(12):2610-6. PubMed ID: 16700038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T; Henke C; Korabiowska M; Schlott T; Zimmerman B; Kunze E
    Anticancer Res; 2004; 24(2B):1011-23. PubMed ID: 15161057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression signature of E2F1 and its associated genes predict superficial to invasive progression of bladder tumors.
    Lee JS; Leem SH; Lee SY; Kim SC; Park ES; Kim SB; Kim SK; Kim YJ; Kim WJ; Chu IS
    J Clin Oncol; 2010 Jun; 28(16):2660-7. PubMed ID: 20421545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly invasive transitional cell carcinoma of the bladder in a simian virus 40 T-antigen transgenic mouse model.
    Grippo PJ; Sandgren EP
    Am J Pathol; 2000 Sep; 157(3):805-13. PubMed ID: 10980120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene discovery in bladder cancer progression using cDNA microarrays.
    Sanchez-Carbayo M; Socci ND; Lozano JJ; Li W; Charytonowicz E; Belbin TJ; Prystowsky MB; Ortiz AR; Childs G; Cordon-Cardo C
    Am J Pathol; 2003 Aug; 163(2):505-16. PubMed ID: 12875971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of genes correlated with early-stage bladder cancer progression.
    Stone R; Sabichi AL; Gill J; Lee IL; Adegboyega P; Dai MS; Loganantharaj R; Trutschl M; Cvek U; Clifford JL
    Cancer Prev Res (Phila); 2010 Jun; 3(6):776-86. PubMed ID: 20501863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transitional cell carcinomas and nonurothelial carcinomas of the urinary bladder differ in the promoter methylation status of the caveolin-1, hDAB2IP and p53 genes, but not in the global methylation of Alu elements.
    Kunze E; Von Bonin F; Werner C; Wendt M; Schlott T
    Int J Mol Med; 2006 Jan; 17(1):3-13. PubMed ID: 16328005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Ras superfamily proteins in bladder cancer progression.
    Oxford G; Theodorescu D
    J Urol; 2003 Nov; 170(5):1987-93. PubMed ID: 14532839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
    Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L
    Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
    Kunze E; Wendt M; Schlott T
    Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profile and enrichment pathways in different stages of bladder cancer.
    Fang ZQ; Zang WD; Chen R; Ye BW; Wang XW; Yi SH; Chen W; He F; Ye G
    Genet Mol Res; 2013 May; 12(2):1479-89. PubMed ID: 23765955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient receptor potential vanilloid type 1 (TRPV1) expression changes from normal urothelium to transitional cell carcinoma of human bladder.
    Lazzeri M; Vannucchi MG; Spinelli M; Bizzoco E; Beneforti P; Turini D; Faussone-Pellegrini MS
    Eur Urol; 2005 Oct; 48(4):691-8. PubMed ID: 15992990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer.
    Juanpere N; Agell L; Lorenzo M; de Muga S; López-Vilaró L; Murillo R; Mojal S; Serrano S; Lorente JA; Lloreta J; Hernández S
    Hum Pathol; 2012 Oct; 43(10):1573-82. PubMed ID: 22417847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.